Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease

Abstract

Deferoxamine improved nitric oxide-mediated, endothelium-dependent vasodilation in patients with coronary artery disease. These results suggest that iron availability contributes to impaired nitric oxide action in atherosclerosis.